Parmax Pharma informs about details of loss of certificate

17 Jun 2023 Evaluate
Parmax Pharma has informed about intimation regarding loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further, pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022 a Letter of Confirmation will be issued to the securities holder/claimant upon completion of necessary procedures regarding duplicate Share Certificate.

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

45.64 1.94 (4.44%)
23-Dec-2024 09:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1811.80
Dr. Reddys Lab 1353.00
Cipla 1475.15
Lupin 2155.60
Zydus Lifesciences 973.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.